When Good Utilization Management Makes Your Numbers Look Bad

A hospital finally fixes its utilization management (UM) program. Next quarter, the case mix index (CMI) goes down; denials go up, and the volume of accounts receivable (AR) increases. Three metrics move in the wrong direction at once, and hospital leadership assumes the initiative backfired.

Then someone checks the net revenue. It’s up, by a lot.

What’s Actually Happening

Borderline two-midnight patients move from outpatient observation services to inpatient status when clinically appropriate and medically necessary. These low-weight Medicare Severity Diagnosis-Related Groups (MS-DRGs) cases are compliant, but they sit at the lower end of the acuity range. You’re adding volume to the inpatient population with cases that are legitimately appropriate under the Medicare Two-Midnight Rule but have lower severity (e.g., no complications/comorbidities or major complication/comorbidities) compared to the rest of the inpatient population. This one shift explains everything below.

Why CMI Falls

CMI is the average MS-DRG relative weight across inpatient discharges over a specific period. Adding lower-weight cases lowers the average. Coding and documentation didn’t get worse; the denominator expanded to include a healthier patient population.

The tell: CMI falling while inpatient volume and overall revenue rise. In contrast, a falling CMI while inpatient volume holds flat, and revenue per case signals decay, is a real problem. A falling CMI must be investigated rather than assumed to be a problem within the revenue cycle.

Why AR Days Climb

Inpatient claims are paid more slowly than observation claims. Higher dollar amounts and complex coding scenarios trigger more scrutiny from payers. Denied claims sit in the receivables aging while they’re being worked. AR days climb as a direct result of the same underlying shift; a higher inpatient population ratio results in more inpatient claims being adjudicated.

A better way to track AR days is to stop looking at one blended AR number. Track inpatient and observation AR days as separate cohorts. If each cohort’s aging is stable and the blended number moved only because the patient status mix moved, that is an artifact of the UM strategy, not a receivables problem.

Why Denials Rise

More inpatient claims mean more claims exposed to inpatient medical necessity review, especially as payer mix shifts towards Medicare Advantage. Adding three hundred inpatient stays to the patient population will increase the raw denial count, making UM efforts appear ineffective.

Instead, track the denial rate (denials per inpatient discharge). More often than not, the rate remains steady or improves. Hospitals must also consider their overturn rate. A high overturn rate means payers are challenging legitimate inpatient stays and losing, which is a defensible-status story, not a UM failure.

Why Net Revenue Wins

Inpatient care generates far more net revenue than observation care for a clinically comparable stay. Net revenue, more than cash collections alone, validates whether accepting slower payment on a much larger claim is the right tradeoff for the organization’s patient-status strategy. And because the cost structure for a given stay is largely similar regarding less patient status, that lift in net revenue generally improves EBITDA, though this could be tempered by increased costs if the change in status also drives a change in length of stay.

Higher AR days, plus higher net revenue, mean the organization is carrying more receivables and converting them into significantly more revenue than before. If net revenue per discharge is falling while CMI falls, that is a failure of the hospital’s revenue cycle. Net revenue per AA
(adjusted admissions) is the number that tells the true story of whether the new UR strategy is successful.

Reading the Four Together

CMI down, denials up, AR days up, net revenue up. That combination is evidence of a mix shift. Real deterioration looks different: CMI falling while revenue per case erodes, denials rising with weak overturn rates, AR aging within a single cohort rather than across the mix, and net revenue flat or falling.

Same four metrics, opposite story. Only segmentation tells you which one you’re in.

The Takeaway

Old benchmarks were built on a case mix that a successful UM program is designed to change. For organizations increasing appropriate inpatient capture, modest CMI dilution may become a natural consequence of changing patient-status mix.

As hospital reimbursement becomes more complex build dashboards around what distinguishes the two stories:

• Case-mix-adjusted views
• Denials per inpatient stay
• Dollars recovered and appeal success rate alongside denied dollars
• Inpatient and observation AR tracked separately
• Net revenue per adjusted admission (NRAA) as the metric that cuts through it all
• Final account write-offs as a check on whether the other metrics are telling the full story

Encourage alignment across UM, CDI, coding, and patient financial services before the quarterly review. If UM is capturing appropriate inpatient volume while finance is independently alarmed by CMI, the organization will inadvertently move back to leaving money and accuracy on the table. The goal is not to improve CMI, reduce AR days, or minimize denial counts. The goal is to maximize appropriate reimbursement while maintaining defensible clinical documentation and sustainable financial performance.

Don’t Let a Healthy Program Get “Corrected” Back into a Problem

If your CMI is dropping and your team can’t yet prove whether that’s dilution or decay, that’s the exact gap we help close. Brundage Group helps finance, revenue cycle, and clinical leaders distinguish between metric deterioration and metric distortion. By integrating UM, CDI, coding, denial, and financial performance data, organizations gain the visibility needed to determine whether a declining CMI reflects true operational weakness or the expected result of a changing patient-status mix.